Pediatrix Medical Group, Inc. Quarterly Goodwill in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Pediatrix Medical Group, Inc. quarterly Goodwill history and growth rate from Q2 2010 to Q4 2024.
  • Pediatrix Medical Group, Inc. Goodwill for the quarter ending December 31, 2024 was $1.24B, a 10.2% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.24B -$142M -10.2% Dec 31, 2024 10-K 2025-02-20
Q3 2024 $1.24B -$293M -19.1% Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $1.24B -$293M -19.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.39B -$139M -9.06% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.38B -$148M -9.66% Dec 31, 2023 10-K 2025-02-20
Q3 2023 $1.53B $0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.53B $0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.53B +$3.4M +0.22% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $1.53B +$26.7M +1.77% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $1.53B +$35.3M +2.36% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.53B +$45M +3.03% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1.53B +$46.2M +3.12% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $1.51B +$27.5M +1.86% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $1.5B +$16.1M +1.09% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $1.49B -$678M -31.3% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $1.48B -$1.23B -45.3% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.48B -$1.88M -0.13% Dec 31, 2020 10-K 2022-02-17
Q3 2020 $1.48B -$1.15B -43.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $2.17B -$1.9B -46.8% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $2.71B -$1.36B -33.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.48B -$2.58B -63.6% Dec 31, 2019 10-K 2021-02-18
Q3 2019 $2.63B -$1.67B -38.8% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $4.07B -$235M -5.46% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $4.07B -$236M -5.49% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $4.06B -$223M -5.19% Dec 31, 2018 10-K 2020-02-20
Q3 2018 $4.3B +$185M +4.5% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $4.3B +$356M +9.03% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $4.3B +$355M +9.01% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $4.28B +$439M +11.4% Dec 31, 2017 10-K 2019-02-14
Q3 2017 $4.12B +$289M +7.56% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $3.95B +$438M +12.5% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $3.95B +$559M +16.5% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $3.85B +$479M +14.2% Dec 31, 2016 10-K 2018-02-14
Q3 2016 $3.83B +$481M +14.4% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $3.51B +$347M +11% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $3.39B +$574M +20.4% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $3.37B +$590M +21.3% Dec 31, 2015 10-K 2017-02-10
Q3 2015 $3.35B +$688M +25.9% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $3.16B +$648M +25.7% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $2.81B +$356M +14.5% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $2.78B +$382M +16% Dec 31, 2014 10-K 2016-02-11
Q3 2014 $2.66B +$305M +13% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 $2.52B +$243M +10.7% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $2.46B +$292M +13.5% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $2.39B +$228M +10.5% Dec 31, 2013 10-K 2015-02-09
Q3 2013 $2.35B +$414M +21.4% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $2.27B +$466M +25.8% Jun 30, 2013 10-Q 2013-07-30
Q1 2013 $2.17B +$394M +22.2% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $2.17B +$419M +24% Dec 31, 2012 10-K 2014-02-12
Q3 2012 $1.94B +$256M +15.2% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $1.81B +$193M +11.9% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 $1.77B +$160M +9.93% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $1.75B +$145M +9.08% Dec 31, 2011 10-K 2013-02-15
Q3 2011 $1.68B +$343M +25.6% Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $1.61B +$277M +20.7% Jun 30, 2011 10-Q 2011-08-02
Q1 2011 $1.61B Mar 31, 2011 10-Q 2011-05-03
Q4 2010 $1.6B Dec 31, 2010 10-K 2012-02-29
Q3 2010 $1.34B Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $1.34B Jun 30, 2010 10-Q/A 2010-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.